Total Occlusion Study in Coronary Arteries - 5

NCT01753180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Coronary Total Occlusions

Interventions

BIOLOGICAL: collagenase
DRUG: saline

Sponsor

Matrizyme Pharma Corporation